Katie Boland Dvm

Katie Boland DVM, MBA, PhD is a seasoned professional in the fields of veterinary medicine, immunology, and business development. Currently serving as the Business Development Director for Sequencing at Tempus AI since February 2024, Katie has previously held multiple leadership roles at Adaptive Biotechnologies Corp., including Director of Strategy in Immune Medicine and Director of Business Development, where contributions to innovative products and strategic market analyses were pivotal. Katie's extensive academic background includes a PhD in Immunology and Veterinary Anatomic Pathology from Washington State University, an MBA from the University of Maine, and a DVM from Michigan State University, complemented by research and training experience in various prestigious institutions, including Memorial Sloan-Kettering Cancer Center and the Washington Animal Disease Diagnostic Laboratory.